Press Release: Onc.AI : Onc.AI Serial Imaging Response Score Outperforms Traditional Methods for Early Assessment of NSCLC Immunotherapy Outcomes

SAN CARLOS, Calif. & WATERLOO, Ontario--(BUSINESS WIRE)--Onc.AI, a digital health company developing AI-driven oncology clinical management solutions, announced that results from a study evaluating the use of serial imaging in advanced non-small cell lung cancer (NSCLC) will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) annual meeting. The multi-institutional study demonstrated improved prediction of overall survival for patients receiving immunotherapy compared to tra